T he Centers for Disease Control and Prevention (CDC) recommends that sexually active men who have sex with men (MSM) be regularly tested for chlamydia (CT) and gonorrhea (GC), and that testing reflect the anatomical sites of potential exposure. 1 Despite recommendations, regular sexually transmitted infection (STI) testing is not widely performed, particularly for rectal STIs. In a sample of human immunodeficiency virus (HIV)-positive MSM in 6 US cities, annual screening rates for STIs were 13.8% to 18.3% for urethral STIs and 2.3% to 8.5% for rectal STIs. 2 HIV-positive MSM receiving care are likely to have more access to STI testing, and as such, these rates may overestimate STI testing rates among all MSM. Further, young MSM (YMSM) are less likely than adult MSM to regularly test for STIs. 3 Given that YMSM have the highest rate of new HIV diagnoses among all age and risk groups 4 and that STIs are associated with HIV transmission risk, 5 research is needed to understand the prevalence of STIs and their risk factors in this population.
There is relatively limited data on the prevalence of rectal and urethral STIs among YMSM. In a 2014 sample of HIV-negative MSM across 26 STI clinics, prevalence was 5.7% for urethral CT, 7.5% for rectal CT, 8.6% for urethral GC, and 5.5% for rectal GC. 6 Prevalence was lower in a US national sample of HIV-negative MSM, 7 such that 1.4% tested positive for urethral CT, 4.4% for rectal CT, 0.5% for urethral GC, and 1.8% for rectal GC. In a community sample of HIV-negative MSM, rectal STIs were also more common than urethral STIs, and CT was more common than GC. 5 In addition, few studies have examined risk factors for STIs among MSM. Grov and colleagues 7 found that younger MSM had greater odds of STIs compared with older MSM, and Latino MSM had greater odds of rectal STIs compared with white MSM. Number of male partners was a risk factor for both urethral and rectal STIs, whereas number of receptive/insertive anal sex acts and number of receptive condomless anal sex (CAS) acts were risk factors for rectal STIs only. Engaging in both insertive and receptive anal sex was associated with increased odds of rectal STIs (compared with insertive sex only) and urethral STIs (compared with receptive sex only). Kelley and colleagues 5 also found that prevalence of rectal CT/GC and urethral GC were higher for black MSM compared with white MSM.
Regarding other contextual factors, there has been debate in the field regarding the association between CAS and meeting partners online or through apps, 8 but very little research has examined the association with STIs. One of the most frequently cited risk factors for CAS is drug use, 9 whereas results have been inconsistent for alcohol use. 10 One study found that methamphetamine use before sex was associated with self-reported STIs among adult MSM 11 and another study found that club drug use was associated with diagnoses of HIV and syphilis among MSM in China.
Despite increased research on STIs among MSM in recent years, several gaps remain. Although Grov and colleagues 7 provided the first national US data on STI prevalence among HIVnegative MSM, the average age of their sample was 40 years and the majority were identified as white. Given that younger, black, and Latino MSM have higher prevalence of STIs, 5, 7 it is important to examine the prevalence among YMSM, including those of color. The current study examined (1) the prevalence of STIs in a large US sample of HIV-negative YMSM (ages 18-29 years) that included a large percentage of men of color (65.7%); and (2) demographic, behavioral, and contextual risk factors. Additionally, the current study examines the feasibility and acceptability of using remote self-collected testing for urethral and rectal STIs among YMSM. Prior studies suggest that self-collection is feasible and acceptable, 7 but it is unclear if this generalizes to YMSM.
MATERIALS AND METHODS

Study Design and Population
Keep It Up! 2.0 is a randomized controlled trial (RCT) of an online HIV prevention program for YMSM. Information about the intervention and the design of the RCT can be found in a previous articles. 13 Participants were recruited in-person in a Atlanta, Chicago, and New York City from HIV testing clinics, health department clinics, street outreach, and referrals from ongoing studies, as well as through online local and national advertisements. 13 In clinics, upon an HIV-negative test result, staff explained the study and offered an eligibility screener. For online recruitment, participants completed screeners online and provisionally eligible participants either obtained an HIV test at a participating site in Atlanta, Chicago, or New York City or were mailed an Food and Drug Administration (FDA)-approved at-home HIV test. Eligible participants were HIV-negative, aged 18 to 29 years, assigned a male sex at birth, currently identified as male, reported CAS with a man in the past 6 months, were not in a behaviorally monogamous relationship for longer than 6 months, were able to read English at an eighth grade level, and had a functioning email address.
The current study uses preintervention data from 1113 participants who completed the assessment between June 2013 and December 2015. Participants completed online self-report measures and self-collected samples for rectal/urethral CT/GC testing. Sample collection could be completed at a recruitment clinic or at home. Those who did it at home were mailed test kits with a placemat that identified all of the materials contained in the shipping container and provided instructions for sample collection (including a link to a video demonstrating collection) and how to return the samples to the laboratory using prepaid shipping containers. Participants who tested positive were provided with results via phone and/or through an encrypted and password protected email message and with local referrals for free or low cost treatment. Positive results were reported to the health department where the participant resided. Procedures were approved by the affiliated institutional review boards.
Laboratory procedures
Specimens were self-collected using the Aptima Urine and Unisex Swab Specimen Collection Kits and tested for CT/GC by the CDC Division of STD Prevention Laboratory using the Aptima Combo 2 CT/NG Assay (Hologic Gen-Probe, San Diego, CA). Specimens were analyzed on the Aptima Panther automated platform system, which has a sensitivity of 94.4% to 98.7% and specificity of 99.7% to 99.8% when male urine is tested for CT/ GC.
14 A prior validation study by the laboratory indicated >95% sensitivity and >99% specificity for rectal swabs; values that are similar to prior validations studies.
15,16
Measures Demographics Participants reported their age, race/ethnicity, sexual orientation, relationship status, and student/employment status.
Behavioral Characteristics
The HIV-Risk Assessment for Sexual Partnerships assessed sexual behaviors in the past 3 months on a partner-by-partner basis for the 3 most recent partners and in aggregate for additional partners. 17 Items used in the current study include number of partners with whom participants had CAS, count of insertive or receptive CAS acts with each partner, whether partners met online, and drug use before sex.
Frequency of drug use in the past 3 months was measured with an adaptation of the National Institute on Drug Abuse modified Alcohol, Smoking, and Substance Involvement Screening Test. 18 Preexposure prophylaxis (PrEP) use was measured with 1 question: "Have you taken anti-HIV medications in the past 3 months before engaging in high-risk sexual behavior (sometimes called PrEP, Truvada, 'taking a T' or using the 3 Vs)?" The wording of this question was finalized before PrEP received FDA approval, and the dosing schedule was determined. Participants were asked during their lifetime which (if any) STIs they were diagnosed with and how many times they were tested for HIV. To reduce the effects of possible spurious outliers, responses to number of past HIV tests were winsorized by transforming values above 3 standard deviations to that value. Frequency of condom failures in the past 3 months was measured with the condom failure subscale of an adapted version of the Condom Use Errors and Problems Questionnaire 19 (eg, "As a bottom during anal sex in the last 3 months, how often did the condom break during sex?"). Responses were on a 5-point scale (1, never; 5, always) and summed across items.
Analyses
We calculated the prevalence of urethral/rectal CT/GC and descriptive statistics for demographics and behavioral characteristics. Likelihood ratio confidence intervals (CI) for binomial proportions were calculated for STI prevalence. χ 2 tests and bivariate/multivariate logistic regressions were used to examine associations between demographics and behavioral characteristics and STIs. Analyses were run with 3 outcomes: (1) urethral STIs; (2) rectal STIs; and (3) total (urethral and rectal) STIs. Analyses were conducted in SPSS 24.
RESULTS
Demographic and behavioral characteristic data are presented in Tables 1 and 2 . The average age of participants was 24.07 years (SD, 3.00). Of 1113 participants, 1001 returned the STI kits (89.9% overall return rate: 992 both rectal and urine, 3 rectal only, and 6 urine only). The STI prevalences are reported in Table 3 . Of those with urethral STIs, 35.3% also had rectal STIs. Of those with rectal STIs, 9.3% also had urethral STIs. Overall, 1.2% (n = 12) tested positive for both rectal and urethral STIs. Chlamydia was more common than GC for rectal (8.8% vs 5.0%) and urethral (2.6% vs 0.9%) infections, and these differences were significant based on nonoverlapping 95% CIs.
Results of χ 2 tests for demographic and categorical predictors of rectal STIs are presented in Tables 1 and 2 . Results are only reported for rectal STIs, because there were no significant associations for urethral or total STIs. The only significant predictor was CAS in the previous 3 months. Rectal STIs were higher among those who had receptive CAS only (19.4%) compared with those who had both receptive and insertive CAS (12.6%), those who did not have CAS in the previous 3 months (but engaged in CAS sometime in the previous 6 months to be eligible for Keep It Up 2.0) (11.8%), and those who had insertive CAS only (8.2%). There were no significant differences in the χ 2 models based on participant age, sexual orientation, race/ethnicity, relationship status, student/employment status, PrEP use, meeting sexual partner online, previous STI diagnosis, or drug use before sex.
Bivariate logistic regression results for continuous predictors of rectal STIs are in Table 4 . Older participants were significantly less likely to have a rectal STI, with each year of age decreasing the odds by 6% (OR, 0.94; CI, 0.88-1.00). Marijuana use in the previous 3 months (OR, 1.09; CI, 1.01-1.18) was significantly associated with higher odds of rectal STIs. Sensitivity analyses were conducted to examine nonlinear effects of independent variables at theoretically meaningful cutpoints (e.g., any drug use versus number of drugs), and results were consistent.
Results for all independent variables in a multivariate logistic regression model are in Table 5 . Rectal STIs were significantly higher for black compared with white YMSM (OR, 1.74; CI, 1.00-3.02). This effect was not significant in bivariate analyses and only emerged as significant in the multivariable analysis that included other cofactors. Receptive CAS with a casual partner was significantly associated with higher odds of rectal STIs (OR, 1.60; CI, 1.05-2.46), whereas insertive CAS with a casual partner was significantly associated with lower odds of rectal STIs (OR, 0.60; CI, 0.40-0.92). No other effects were significant in the multivariable analysis.
DISCUSSION
We found a high prevalence of STIs in our sample, most of which were rectal. Our prevalence was slightly higher than previous studies, 6, 7 which is likely due to our study requiring participants to have recently engaged in CAS. Our sample was also younger and had a higher proportion of racial minorities, both of which are risk factors for rectal STIs. 5, 7 Consistent with this, the prevalence of rectal STIs in our sample was higher among younger and Black participants. Also consistent with previous studies of MSM, 5, 7 Chlamydia was more common than GC, and rectal STIs were more common than urethral STIs. Such high prevalence of rectal STIs are concerning given that regular STI testing is not widely performed, especially for rectal STIs, 2 and that younger MSM are also less likely to regularly test for STIs. 3 This puts YMSM at higher risk for having an unknown rectal STI, contributing to forward transmission to partners. Several potential explanations have been proposed for why rectal STIs are more common than urethral STIs among MSM. 7 First, YMSM may not recognize that they have rectal STIs, because they are often asymptomatic or symptoms are less noticeable than with urethral STIs. 20 Second, providers and patients may be uncomfortable with rectal STI testing. 21 Third, YMSM may have a misconception that urine/blood tests for other STIs will detect STIs at all anatomical sites. 22 Fourth, nucleic acid amplification tests for extragenital CT/GC have not been FDA-approved despite CDC recommendations for their use, 23 so providers need to use laboratories that performed a validation study demonstrating acceptable sensitivity/specificity for the testing of rectal swabs.
The prevalence of rectal STIs was higher among black compared with white MSM in our sample and previous research. 5, 7 There was also a trend for a higher prevalence among Latinos. Black MSM have the highest prevalence of new HIV diagnoses, and the rate is increasing for Latino MSM. 4 Given the established association between STIs and HIV transmission risk, 5 detecting and treating rectal STIs may reduce racial disparities in HIV. Although population-based STI treatment among heterosexuals in Africa was not found to decrease HIV transmission, 24 populations with high-risk behaviors and high prevalence of STIs may benefit more than populations with generalized epidemics. 25 A simulation estimated that 14.6% of HIV infections among YMSM were due to CT/GC, with the majority attributed to rectal infections. 26 Another study estimated that nearly 15% of HIV infections may have been prevented if rectal STIs had not occurred. 5 Thus, identifying risk factors for rectal STIs has the potential to inform prevention efforts, promote detection and treatment, and reduce STI/HIV transmission. Screening MSM for rectal STIs has been shown to be cost-effective (or cost-saving depending on assumptions), based on its impact in averting new HIV infections. 27 Consistent with Grov and colleagues, 7 we found that receptive CAS was associated with rectal STIs. In fact, 19.4% of YMSM who reported receptive CAS had rectal STIs. Prevalence of rectal STIs was also high among those who did not report recent CAS in the previous 3 months (11.8%) and those who only reported insertive CAS (8.2%), suggesting that recent receptive CAS should not be the sole criterion for rectal STI testing. The small number of urethral STIs may have limited our ability to detect similar significant associations between CAS and urethral STIs.
Although we found a significant bivariate association between marijuana use and rectal STIs, it became nonsignificant in a multivariable analysis, and we did not find a significant association between polydrug use and STIs. The reduced effect of marijuana use in the multivariable analysis implies a potential indirect effect via receptive CAS that should be investigated in future longitudinal studies that can test mediation. Similarly, Grov and colleagues found that the association between drug use and rectal STIs became nonsignificant after accounting for demographics.
The current findings have important implications for clinical practice and future research. Given that most of the STIs in our sample were rectal, providers who only use urine-based testing will miss the majority of CT/GC among YMSM. If we had only used urine-based testing, we would have missed 117 people who tested positive for rectal STIs, but negative for urethral STIs (77.5% of those who tested positive for any STI). Some participants denied recent receptive anal sex, but tested positive for rectal STIs. These participants may be more likely to underreport their behavior, or may have acquired a rectal STI before the past 3 months, given that rectal STIs may persist for a year without treatment. 28 The cross-sectional nature of our study limited our ability to test temporality. It will be important for future research to use longitudinal designs to test whether the risk factors are associated with incident STI diagnoses over time. It is also possible that some men felt uncomfortable disclosing that they had engaged in receptive anal sex even in our online survey. If true, it is likely that they will be even less comfortable disclosing this to a clinician. Clinicians are encouraged to create a nonjudgmental environment to facilitate discussions of sexual health by including questions about sexual orientation and behavior on intake forms and initiating these conversations. When assessing sexual health, all men should be asked about insertive and receptive sexual behavior with male and female partners. For researchers, it is important to separate insertive and receptive anal sex in analyses. We found that they had opposite associations with rectal STIs, which would have been overlooked if they were not separated or we focused on broad measures like number of CAS partners.
Our study demonstrated that distance self-collection of specimens for STI testing is feasible, which is important because it provides an opportunity to increase the coverage of STI screening for MSM, including rural MSM and MSM who do not have access to clinics offering rectal testing. Rectal STI screening has been found to be acceptable in a large cohort of urban MSM provided with collection kits at clinic visits 5 and in a national online 29 However, pharyngeal specimen collection has been demonstrated to be acceptable to MSM 30 and could readily be added to future studies of self-collected specimens for STI testing among YMSM.
The current findings call attention to the high prevalence of rectal STIs among YMSM and the need for health care providers to screen and test for them. They also point to risk factors that can be targeted by prevention programs to reduce incident STIs. Additionally, our study demonstrates the feasibility and acceptability of using self-collected samples for urethral/rectal STI testing among YMSM in the context of an eHealth intervention. It also demonstrates how home-based sample collection can be used to deliver STI testing without geographic boundaries as part of an eHealth program. 
